ClinicalTrials.govpublic full text
Safety, Tolerability, and Preliminary Antitumor Activity of Cationic Peptide-IL22BP mRNA in Advanced Solid Tumors
mrna vaccine, solid tumor cancer, peptides, cancer metastatic
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 414364
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.